Biocon dips marginally as Syngene plans for IPO

The company's subsidiary - Syngene International filed a Draft Red Herring Prospectus with the Securities and Exchange Board of India for an IPO.

Apr 23, 2015 10:04 IST India Infoline News Service

Biocon Limited
Biocon surged over 3% to a high of Rs. 470 after the company's subsidiary - Syngene International filed a Draft Red Herring Prospectus with the Securities and Exchange Board of India for an IPO. 
The stock, however, ended down nearly a percent at Rs. 452 at the BSE counter. 
The stock has hit a high of RS. 470 and a low of Rs. 449.

Related Story